{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:27:36Z","timestamp":1792888056903,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012487","name":"Interdisciplinary Medicine Seed Fund of Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012487","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21807006"],"award-info":[{"award-number":["21807006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273772"],"award-info":[{"award-number":["82273772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["BMU2020MX016"],"award-info":[{"award-number":["BMU2020MX016"]}],"id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejmech.2023.115393","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T19:38:30Z","timestamp":1682105910000},"page":"115393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization"],"prefix":"10.1016","volume":"255","author":[{"given":"Cangxin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-8950","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115393_bib1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115393_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2023.115393_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in cancer","volume":"11","author":"Koren","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2023.115393_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s10020-022-00594-2","article-title":"The emerging role of pyroptosis-related inflammasome pathway in atherosclerosis","volume":"28","author":"Xu","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejmech.2023.115393_bib5","article-title":"Manf enhances the pyroptosis inhibition of bone marrow-derived mesenchymal stem cells to relieve cerebral infarction injury","author":"Zhang","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2023.115393_bib6","article-title":"Oxeiptosis: a novel pathway of melanocytes death in response to oxidative stress in vitiligo","volume":"8","author":"Kang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2023.115393_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coi.2018.10.006","article-title":"Oxeiptosis: a discreet way to respond to radicals","volume":"56","author":"Scaturro","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejmech.2023.115393_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2020.100290","article-title":"Fluorescence nanoparticles from instant coffee accumulated in lysosome and induced lysosome-dependent cell death via necroptosis-like pathway","volume":"21","author":"Wu","year":"2021","journal-title":"Nanoimpact"},{"key":"10.1016\/j.ejmech.2023.115393_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03394-4","article-title":"FV-429 induces autophagy blockage and lysosome-dependent cell death of T-cell malignancies via lysosomal dysregulation","volume":"12","author":"Hu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2023.115393_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbi.2021.01.003","article-title":"ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation","volume":"93","author":"Cui","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejmech.2023.115393_bib11","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115393_bib12","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2147\/JIR.S307081","article-title":"Role of ferroptosis in lung diseases","volume":"14","author":"Xu","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejmech.2023.115393_bib13","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.7150\/ijms.62903","article-title":"Ferroptosis and liver fibrosis","volume":"18","author":"Pan","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2023.115393_bib14","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/s41418-020-0528-x","article-title":"Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia\/reperfusion-induced acute lung injury","volume":"27","author":"Li","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2023.115393_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00267","article-title":"Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases","volume":"14","author":"Song","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115393_bib16","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1038\/s41418-019-0299-4","article-title":"Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia\/reperfusion","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2023.115393_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115393_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","article-title":"The chemistry and biology of ferroptosis","volume":"27","author":"Stockwell","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115393_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115393_bib20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115393_bib21","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1038\/s41467-021-27414-1","article-title":"Molecular basis for redox control by the human cystine\/glutamate antiporter system xc-","volume":"12","author":"Parker","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115393_bib22","doi-asserted-by":"crossref","first-page":"19655","DOI":"10.1074\/jbc.M601195200","article-title":"The role of phospholipid hydroperoxide glutathione peroxidase isoforms in murine embryogenesis","volume":"281","author":"Borchert","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115393_bib23","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","article-title":"Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins","volume":"274","author":"Sato","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115393_bib24","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1021\/bi700840d","article-title":"Structural basis for catalytic activity and enzyme polymerization of phospholipid hydroperoxide glutathione peroxidase-4 (GPx4)","volume":"46","author":"Scheerer","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.115393_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115393_bib26","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115393_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2023.115393_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","article-title":"Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles","volume":"16","author":"Eaton","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115393_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","article-title":"FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation","volume":"14","author":"Gaschler","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115393_bib30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115393_bib31","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2023.115393_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115393_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114290","article-title":"The state of the art of PROTAC technologies for drug discovery","volume":"235","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115393_bib34","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.bmcl.2008.07.114","article-title":"Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics","volume":"18","author":"Schneekloth","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115393_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","article-title":"The advantages of targeted protein degradation over inhibition: an RTK case study","volume":"25","author":"Burslem","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.ejmech.2023.115393_bib36","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective small molecule induced degradation of the BET bromodomain protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115393_bib37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115393_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/srep20390","article-title":"Selective and reversible suppression of intestinal stem cell differentiation by pharmacological inhibition of BET bromodomains","volume":"6","author":"Nakagawa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115393_bib39","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1002\/anie.201901336","article-title":"Development of dual and selective degraders of cyclin-dependent kinases 4 and 6","volume":"58","author":"Jiang","year":"2019","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2023.115393_bib40","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1039\/C7CC03879H","article-title":"Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)","volume":"53","author":"Robb","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2023.115393_bib41","first-page":"92","article-title":"Discovery of coumarin-based MEK1\/2 PROTAC effective in human cancer cells","author":"Wang","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115393_bib42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the 'undruggable' cancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115393_bib43","doi-asserted-by":"crossref","first-page":"16967","DOI":"10.1039\/C9RA03423D","article-title":"Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery","volume":"9","author":"Pei","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115393_bib44","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1021\/acsmedchemlett.0c00192","article-title":"PROTAC compounds targeting alpha-synuclein protein for treating neurogenerative disorders: alzheimer's and Parkinson's diseases","volume":"11","author":"Kargbo","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115393_bib45","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/s41467-019-11429-w","article-title":"Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations","volume":"10","author":"de Wispelaere","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115393_bib46","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cell.2021.02.013","article-title":"Antivirals with common targets against highly pathogenic viruses","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115393_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115072","article-title":"Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect","volume":"247","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115393_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114259","article-title":"Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold","volume":"236","author":"Chen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115393_bib49","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.chembiol.2022.11.003","article-title":"Small-molecule allosteric inhibitors of GPX4","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.ejmech.2023.115393_bib50","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1021\/acs.jmedchem.3c00075","article-title":"Discovery of a potent, cooperative, and selective SOS1 PROTAC ZZ151 with in vivo antitumor efficacy in KRAS-mutant cancers","volume":"66","author":"Zhou","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423003598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423003598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:51:02Z","timestamp":1759330262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423003598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":50,"alternative-id":["S0223523423003598"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115393","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115393"}}